Literature DB >> 2507316

Intermolecular disulfide bonds are not required for the expression of the dimeric state and functional activity of the transferrin receptor.

E Alvarez1, N Gironès, R J Davis.   

Abstract

The human transferrin receptor is expressed as a disulfide-linked dimer at the cell surface. The sites of intermolecular disulfide bonds are Cys-89 and Cys-98. We have examined the functional significance of the covalent dimeric structure of the transferrin receptor by substitution of Cys-89 and Cys-98 with serine residues. Wild-type and mutated transferrin receptors were expressed in Chinese hamster ovary cells (clone TF-) that lack detectable endogenous transferrin receptors. The rates of receptor endocytosis and recycling were measured and the accumulation of iron by cells incubated with [59Fe]diferric transferrin was investigated. No significant differences between these rates were observed when cells expressing wild-type and mutated receptors were compared. The structure of the mutant receptor lacking intermolecular disulfide bonds was investigated. The presence of a population of mutant receptors with a non-covalent dimeric structure was indicated by cross-linking studies using diferric [125I]transferrin and the bifunctional reagent disuccinimidyl suberimidate. However, sucrose density gradient sedimentation analysis of Triton X-100 solubilized transferrin receptors demonstrated that the mutant receptor existed as a monomer in the absence of diferric transferrin and as an apparent dimer in the presence of this receptor ligand. We conclude that the covalent dimeric structure of the transferrin receptor is not required for the expression of the dimeric state and functional activity of the receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507316      PMCID: PMC401153          DOI: 10.1002/j.1460-2075.1989.tb08347.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis.

Authors:  H S Wiley; D D Cunningham
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

2.  Biosynthesis of the human transferrin receptor in cultured cells.

Authors:  M B Omary; I S Trowbridge
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

3.  Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.

Authors:  I S Trowbridge; F Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

4.  Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9.

Authors:  C Schneider; R Sutherland; R Newman; M Greaves
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

5.  Murine cell surface transferrin receptor: studies with an anti-receptor monoclonal antibody.

Authors:  I S Trowbridge; J Lesley; R Schulte
Journal:  J Cell Physiol       Date:  1982-09       Impact factor: 6.384

6.  Selection of cell lines resistant to anti-transferrin receptor antibody: evidence for a mutation in transferrin receptor.

Authors:  J F Lesley; R J Schulte
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

Authors:  R Sutherland; D Delia; C Schneider; R Newman; J Kemshead; M Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

9.  Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells.

Authors:  J E Lamb; F Ray; J H Ward; J P Kushner; J Kaplan
Journal:  J Biol Chem       Date:  1983-07-25       Impact factor: 5.157

10.  Covalent binding of fatty acid to the transferrin receptor in cultured human cells.

Authors:  M B Omary; I S Trowbridge
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  14 in total

1.  Down-regulation of cell surface receptors is modulated by polar residues within the transmembrane domain.

Authors:  L Zaliauskiene; S Kang; C G Brouillette; J Lebowitz; R B Arani; J F Collawn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking.

Authors:  Deanna M Navaroli; Zachary H Stevens; Zeljko Uzelac; Luke Gabriel; Michael J King; Lawrence M Lifshitz; Harald H Sitte; Haley E Melikian
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

3.  The LDL receptor-related protein can form homo-dimers in neuronal cells.

Authors:  Alexandra Makarova; Kathryn K Bercury; Kenneth W Adams; Daniel Joyner; Meihua Deng; Robert Spoelgen; Mirjam Koker; Dudley K Strickland; Bradley T Hyman
Journal:  Neurosci Lett       Date:  2008-06-28       Impact factor: 3.046

4.  Lipid stress inhibits endocytosis of melanocortin-4 receptor from modified clathrin-enriched sites and impairs receptor desensitization.

Authors:  Kimberly A Cooney; Brent M Molden; Nicholas S Kowalczyk; Susan Russell; Giulia Baldini
Journal:  J Biol Chem       Date:  2017-09-06       Impact factor: 5.157

5.  Molecular evolution of the transferrin receptor/glutamate carboxypeptidase II family.

Authors:  Lisa Ann Lambert; Stacey L Mitchell
Journal:  J Mol Evol       Date:  2006-12-09       Impact factor: 2.395

6.  Labile disulfide bonds are common at the leucocyte cell surface.

Authors:  Clive Metcalfe; Peter Cresswell; Laura Ciaccia; Benjamin Thomas; A Neil Barclay
Journal:  Open Biol       Date:  2011-11       Impact factor: 6.411

7.  Computational structure models of apo and diferric transferrin-transferrin receptor complexes.

Authors:  Tetsuya Sakajiri; Takaki Yamamura; Takeshi Kikuchi; Hirofumi Yajima
Journal:  Protein J       Date:  2009-12       Impact factor: 2.371

8.  A point mutation in the cytoplasmic domain of the transferrin receptor inhibits endocytosis.

Authors:  E Alvarez; N Gironès; R J Davis
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

9.  Cell surface transport, oligomerization, and endocytosis of chimeric type II glycoproteins: role of cytoplasmic and anchor domains.

Authors:  A Kundu; M A Jabbar; D P Nayak
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

10.  The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.

Authors:  Norbert Schülke; Olga A Varlamova; Gerald P Donovan; Dangshe Ma; Jason P Gardner; Donna M Morrissey; Robert R Arrigale; Cenchen Zhan; Amy J Chodera; Kenneth G Surowitz; Paul J Maddon; Warren D W Heston; William C Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.